Allergic Rhinitis Market Research Report Covers Historical Market Trends, Current Market Dynamics, Market Valuation by Segmentation as Well as Region, Country-level Analysis for Every Segment, Key Player’s Market Share Analysis, Competitive Landscape.
Get Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/1547
Allergic Rhinitis is an allergic reaction caused due to the presence of allergen bacteria such as Pollen. Itchy nose & eyes, frequent inflammation of the nose, sneezing, nasal clogging, mucus in the throat, and a runny nose are some of the prominent symptoms led by the Allergic Rhinitis. This condition is contagious and affects the human respiratory system, severely.
Hence, at the starting of every allergic rhinitis season, Health & Prevention Ministries, worldwide not only release alert to their respective citizens but also take up various programs to provide comprehensive and integrated healthcare as part of community wellness strategy.
The global allergic rhinitis market is well established with a range of novel treatments available to treat the condition. The size of the market is ever-increasing. Moreover, factors such as the proliferation of FDA-approved rapid diagnostic and testing methodologies escalate the market on the global platform.
Acknowledging the exponential accruals, the market is garnering currently, Market Research Future (MRFR) in its recently published analysis asserts that the size of the global allergic rhinitis market will reach USD 15 BN by 2023, posting approximately 7% CAGR throughout the assessment period (2017 – 2023).
Major Players:
- Key players leading the global allergic rhinitis market include
- GSK
- Merck
- Sanofi
- Himalaya
- Cigna
- J&J
- FaesFarma
- Chong Kun Dang Pharmaceutical Corp.
- Glenmark Pharmaceutical
- Hisamitsu Pharmaceutical
- Olain Farm
- Ampio pharmaceutical
Global Allergic Rhinitis Market – Segments
For ease of understanding, the market is segmented into four key dynamics: –
By Type : Seasonal, Perennial, and Non-allergic rhinitis among others.
By Treatment : Decongestants (Afrin nasal spray, Sudafed, Sudafed PE, and Zyrtec-D), Antihistamines (Allegra, Clarinex, Xyzal & Zyrtec), Eye drops, Nasal sprays, and others (immunotherapy, sublingual immunotherapy (SLIT) & home remedies).
By Test : IgE RAST Test, Skin Test, Complete Blood Count, and others.
By Regions : North America, Europe, Asia Pacific, and the Rest-of-the-World (RoW).
Regional Analysis:
The global allergic rhinitis market is segmented into the Americas, Europe, Asia Pacific, and the Middle East and Africa on the basis of region.
North America is likely to be the dominant regional player in the global allergic rhinitis market over the forecast period due to the widespread awareness about allergic rhinitis and the growing prevalence of the disease. The U.S. has the highest incidence rate of hay fever in the world, ensuring North America’s dominance in the global allergic rhinitis market. Europe is also likely to be a major regional player in the global allergic rhinitis market and is likely to hold on to the second position in the market over the forecast period.
Awareness about hay fever is lacking in underdeveloped regions such as Latin America, Africa, and Asia Pacific. Even in regions where people are aware about the disease, most prefer to cure it by herbal home remedies instead of visiting the physician. This is likely to hold back the allergic rhinitis market in Asia Pacific over the forecast period.
Global Allergic Rhinitis Market – Competitive Landscape
Highly competitive, the allergic rhinitis market appears to be fragmented with several large & small key players forming a competitive landscape. These players incorporate strategic initiatives such as partnership, acquisition, expansion, product & technology launch, and collaboration to gain an edge over their competitors. They invest substantially in R&D to develop a medical device or treatment procedure using advanced techniques.
Industry, Innovation & Related News
March 04, 2019 —– Stryker Corporation (the US), a leading global medical technologies firm announced the acquisition of Arrinex, Inc. (the US), a medical device company, developing medical procedure used in patients with refractory chronic rhinitis. Through this acquisition, Stryker plans to extend its offerings using Arrinex’s FDA-approved cryoablation device to treat chronic adult rhinitis.
Stryker also confirmed that it would continue to acquire firms and technologies needed to fill gaps in its offerings. This acquisition also aligns with Stryker focus on providing ENT physicians with new technologies that deliver more treatment options and better patient outcomes.
Intended Audience
- Medical research and development institutes
- Pharmaceutical companies
- Biophramaceutical companies
- Herbal and ayurveda companies
Read Complete Report With TOC @ https://www.marketresearchfuture.com/reports/allergic-rhinitis-market-1547
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com
